a Department of Pharmaceutics , H. R. Patel Institute of Pharmaceutical Education and Research , Karwand Naka, Shirpur, Maharashtra , India.
Artif Cells Nanomed Biotechnol. 2015;43(6):413-24. doi: 10.3109/21691401.2014.898646. Epub 2014 Apr 1.
We report the development of Layer-by-Layer (LbL) polyelectrolyte self-assembled nanocrystalline drug-delivery platform using two experimental factors, namely the number of coatings and temperature during deposition with three varying levels. The optimized formulation (Fopt) was assessed for zeta potential and particle size using Fourier Transform Infrared Spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), and Scanning Electron Microscopy (SEM). Charge reversal along with an increase in particle size confirmed coating of polyelectrolyte on drug nanocrystals. The FT-IR study revealed no signs of incompatibility or change in formulation property during preformulation and stability study. This fact was further supported by DSC results.
我们报告了使用两种实验因素(即涂层数量和沉积过程中的温度)开发层状(LbL)聚电解质自组装纳米晶药物递送平台的情况。使用傅里叶变换红外光谱(FT-IR)、差示扫描量热法(DSC)和扫描电子显微镜(SEM)对优化配方(Fopt)的 ζ 电位和粒径进行了评估。电荷反转和粒径增加证实了聚电解质在药物纳米晶体上的涂层。FT-IR 研究表明,在配方前研究和稳定性研究过程中,没有不相容或配方性质变化的迹象。这一事实得到了 DSC 结果的进一步支持。